Anavex Life Sciences Corp (AVXL)

[Anshu2]

CEOs, in all likelihood, have a LEGAL right to not reveal “everything” to the public. Of course — since revealing “everything” is practically impossible.

They are however required to reveal material information— but what is “material” can be very subjective.

So, CM not revealing all the adverse events in P2a is very likely legal — in which case, why should he reveal it?

SRPT had been very transparent and forthright — but they still hid the actual WB dystrophin expression number in Etepletsin’s trial from public (public came to know about it only through 2016 FDA’s briefing documents). I was quite shocked, that they hid — but I realize they weren’t obligated to reveal, so why would they expose themselves unnecessarily.

Same reason — AVXL doesn’t want to reveal ADL numbers. That’s fine — but going back-and-forth with endpoint measures is plain lying — and must be of questionable legality.